A potent SARS-CoV-2 neutralising nanobody shows therapeutic efficacy in the Syrian golden hamster model of COVID-19 (2021)

First Author: Huo J

Attributed to: Translating potent SARS-Cov-2 neutralising nanobodies from the lab to the clinic funded by COVID

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.21203/rs.3.rs-548968/v1

Publication URI: http://dx.doi.org/10.21203/rs.3.rs-548968/v1

Type: Preprint